LYNNE MELCHIOR: Open Payments
NPI 1811232481 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 38 payments from 13 companies in 2025. Trend: 2023 $1,016 · 2024 $915 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 15 | $235 |
| BETA BIONICS, INC. | 5 | $98 |
| Tandem Diabetes Care, Inc. | 5 | $78 |
| Novo Nordisk Inc | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| CeQur Corporation | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Amgen Inc. | 1 | $19 |
Products named: Omnipod, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ, Rybelsus, CeQur Simplicity, GVOKE HYPOPEN, RECORLEV, Kerendia.
Industry payments across IN — which companies pay providers there.
